Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 1973-1976

  Bajaksouzian, S ^a   Visalli, M A ^b   Jacobs, M R ^a   Appelbaum, P C ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFPIROME; CEPHALOSPORIN DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029834361     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.1973     Document Type: Article

References (24)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae - an overview. Clin. Infect. Dis. 15:77-83.
2. Barry, A. L., S. D. Brown, and W. J. Novick. 1995. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 39:2193-2196.
3. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
4. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore.
5. Fitoussi, F., C. Doit, A. Sandin, A. Pechinot, A. Kazmierczak, P. Geslin, and E. Bingen. 1995. Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile. Antimicrob. Agents Chemother. 39:2560-2563.
6. Friedland, I. R., and G. S. Istre. 1992. Management of penicillin-resistant pneumococcal infections. Pediatr. Infect. Dis. J. 11:433-435.
7. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
8. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
9. Goldstein, F. W., P. Geslin, J. F. Acar, and the French Study Group. 1994. Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistant Streptococcus pneumoniae. Eur. J. Clin. Microbiol. Infect. Dis. 13:33-34.
10. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333: 481-486.
11. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
12. Klugman, K. P., and T. Capper. 1995. In vitro activity of cefpirome against penicillin-resistant pneumococci and its synergistic combination with vancomycin, abstr. 87, p. 17. In Abstracts of 7th European Congress of Clinical Microbiology and Infectious Diseases 1995.
13. Klugman, K. P., I. R. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
14. McDougal, L. K., R. Facklam, M. Reeves, S. Hunter, J. M. Swenson, B. C. Hill, and F. C. Tenover. 1992. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob. Agents Chemother. 36:2176-2184.
15. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
16. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard. NCCLS publication M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing, 5th informational supplement. NCCLS publication M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1995. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology Antimicrob. Agents Chemother. 38:2065-2072.
19. Paris, M. M, O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
20. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1992. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, Win 57273, ofloxacin and ciprofloxacin. Antimicrob. Agents Chemother. 36:856-859.
21. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob. Agents Chemother. 38:898-900.
22. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163: 1273-1278.
23. Täuber, M. G., C. J. Hackbarth, K. G. Scott, M. G. Rusnak, and M. A. Sande. 1985. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob. Agents Chemother. 27:340-342.
24. Viladrich, P. F., F. Gudiol, J. Liñares, R. Pallarés, I. Sabaté, G. Rufí, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 35:2467-2472.